Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Research to Prevent Blindness
Grant: Special Scholar Award
National Eye Institute
Grant: R01EY029750
National Eye Institute
Grant: R01EY025705
Research to Prevent Blindness
Grant: Unrestricted Grant
Alcon Research Institute
Grant: Alcon Young Investigator Award
NEI NIH HHS
Grant: R01 EY032104
National Institutes of Health
Grant: 5R01EY029750-02
Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal Disease
National Institutes of Health
Grant: 5R01EY025705-04
Promotion of retinal vascular hyperpermeability and macular edema by ANGPTL4
FWCI
2.55
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals